Jamie N. Leckie

Jun 4, 2024 | mdpi.com | Jamie N. Leckie |Toshifumi Yokota

All articles published by MDPI are made immediately available worldwide under an open access license. No specialpermission is required to reuse all or part of the article published by MDPI, including figures and tables. Forarticles published under an open access Creative Common CC BY license, any part of the article may be reused withoutpermission provided that the original article is clearly cited. For more information, please refer tohttps://www.mdpi.com/openaccess.

May 6, 2024 | preprints.org | Jamie N. Leckie |Toshifumi Yokota

Preprint Review Version 1 This version is not peer-reviewed Version 1 : Received: 6 May 2024 / Approved: 6 May 2024 / Online: 6 May 2024 (09:54:35 CEST) Leckie, J.; Yokota, T. Potential of Cell-Penetrating Peptide-Conjugated Antisense Oligonucleotides for the Treatment of SMA. Preprints 2024, 2024050274. https://doi.org/10.20944/preprints202405.0274.v1 Leckie, J.; Yokota, T. Potential of Cell-Penetrating Peptide-Conjugated Antisense Oligonucleotides for the Treatment of SMA.

Jun 5, 2023 | odt.co.nz | Jamie N. Leckie |Mark Bunyan |Helen Kettings |Murray Leckie

You are not permitted to download, save or email this image. Visit image gallery to purchase the image.